Covista Inc.

Valuation Analysis

About the Company

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company offers degree and non-degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Med

Covista Inc. Stock at a Glance

Covista Inc. (CVSA) is currently trading at $128.40 with a market capitalization of $4.4B. The trailing P/E ratio stands at 18.69x, with a forward P/E of 14.45x. The 52-week range spans from $86.97 to $156.26; the current price is 17.8% below the yearly high. Year-over-year revenue growth stands at +4.5%. The net profit margin stands at 12.26%.

💰 Dividend

Covista Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

4 analysts rate Covista Inc. (CVSA) on consensus: Strong Buy. The average price target is $156.25, implying +21.69% from the current price. Analyst price targets range from $140.00 to $175.00.

Covista Inc.: The Investment Case in Detail

Covista Inc. (CVSA) operates in the Consumer Defensive — specifically Education & Training Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

The combination of a 57.28% gross margin and 18.93% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Wall Street consensus sits at Strong Buy with an average price target implying roughly 21.69% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

Revenue growth has slowed to just 4.5%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

Valuation in Context

With a PEG ratio of 0.88, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

What to Watch Next

• The forward P/E of 14.45x is meaningfully below the trailing 18.69x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 21.69% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (6.5%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Covista Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.